Identification of Subclinical Myocardial Dysfunction in Breast Cancer Patients with Metabolic Syndrome after Cancer-Related Comprehensive Therapy

BACKGROUND: Breast cancer patients with metabolic syndrome have an increased risk of cardiovascular disease. These patients are more prone to suffer from cardiotoxicity after anticancer therapy. Patients after completion of cancer-related comprehensive therapy, who show normal myocardial function, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng, Wang, Siyuan, Liang, Siying, Yu, Chao, Li, Sufang, Chen, Hong, Wang, Shu, Zhu, Tiangang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943305/
https://www.ncbi.nlm.nih.gov/pubmed/33747560
http://dx.doi.org/10.1155/2021/6640673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943305/
https://www.ncbi.nlm.nih.gov/pubmed/33747560
http://dx.doi.org/10.1155/2021/6640673

Ejemplares similares